Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: Hostmore non-exec buys half a million shares

(Sharecast News) - Hostmore shares were in the red on Monday afternoon, after it disclosed two purchases made by a non-executive director. The company, which operates the TGI Fridays and 63rd+1st restaurant brands in the UK, said Stephen Welker bought 500,000 shares on 22 September, and another 312,500 on 23 September.

His single transaction on 22 September saw him spend £82,915.50 at a share price of 16.58p each.

On 23 September, Welker made the purchases in two tranches, with the first being for 250,000 shares at 16.58p apiece for a total value of £42,457.75.

The second tranche saw him buy 62,500 shares for 16.7p each, for a value of £10,437.50.

Following the purchase, Hostmore said Welker held a total of 4,045,850 shares, of which 189,268 shares were held in his own name and 3,856,582 shares were held by Beechenbrook Holdings LLC, of which Welker is the sole owner.

At 1422 BST, shares in Hostmore were down 0.77% at 16.77p.

Reporting by Josh White at Sharecast.com.

Top Director Buys

Hostmore (MORE) Director name: Welker ,Stephen Amount purchased: 500,000 @ 16.58p Value: £82,915.50

Hostmore (MORE) Director name: Welker ,Stephen Amount purchased: 250,000 @ 16.58p Value: £41,457.75

888 Holdings (di) (888) Director name: Mendelsohn,Jonathan (Jon) Amount purchased: 28,015 @ 117.70p Value: £32,973.66

Cvs Group (CVSG) Director name: Fairman,Richard Amount purchased: 1,205 @ 1,658.54p Value: £19,985.41

Cvs Group (CVSG) Director name: Jacklin,Ben Amount purchased: 1,228 @ 1,627.01p Value: £19,979.68

Cvs Group (CVSG) Director name: Jacklin,Ben Amount purchased: 1,227 @ 1,628.28p Value: £19,979.00

Centralnic Group (CNIC) Director name: Royde ,Max Amount purchased: 14,000 @ 115.93p Value: £16,230.20

Cvs Group (CVSG) Director name: Wilton,David Amount purchased: 1,000 @ 1,618.53p Value: £16,185.30

Centralnic Group (CNIC) Director name: Royde ,Max Amount purchased: 10,823 @ 117.52p Value: £12,719.19

European Assets Trust (EAT) Director name: Breuer,Martin Amount purchased: 14,300 @ 83.00p Value: £11,869.00

Centralnic Group (CNIC) Director name: Royde ,Max Amount purchased: 10,085 @ 117.36p Value: £11,835.76

Chariot Limited (CHAR) Director name: Hockey,Andrew R. Amount purchased: 60,000 @ 18.44p Value: £11,064.00

Hostmore (MORE) Director name: Welker ,Stephen Amount purchased: 62,500 @ 16.70p Value: £10,437.50

Londonmetric Property (LMP) Director name: Wilton,Rosalyn Amount purchased: 5,432 @ 183.00p Value: £9,940.56

Londonmetric Property (LMP) Director name: Wilton,Rosalyn Amount purchased: 5,663 @ 175.00p Value: £9,910.25

Games Workshop Group (GAW) Director name: Rountree,Kevin Amount purchased: 111 @ 7,437.00p Value: £8,255.07

Centrica (CNA) Director name: Rudd ,Amber Amount purchased: 2,508 @ 76.58p Value: £1,920.71

Top Director Sells

Smith (ds) (SMDS) Director name: Marsh ,Adrian Amount sold: 38,493 @ 263.50p Value: £101,429.05

Share this article

Related Sharecast Articles

Director dealings: Blue Coast raises stake in Everyman Media
(Sharecast News) - Everyman Media revealed on Thursday that Blue Coast had acquired 50,000 ordinary shares in the AIM-listed cinema group.
Director dealings: Angus Energy CEO ups stake
(Sharecast News) - Angus Energy revealed on Wednesday that chief executive Richard Herbert had acquired 5.0m ordinary shares in the AIM-listed onshore oil and gas development firm.
Director dealings: Abrdn CEO makes share sale
(Sharecast News) - Abrdn revealed on Monday that chief executive Stephen Bird had disposed of 29,942 ordinary shares in the FTSE 250-listed global investment company.
Director dealings: Redx Pharma CEO ups stake
(Sharecast News) - Redx Pharma revealed on Friday that chief executive Lisa Anson had acquired 399,000 ordinary shares in the AIM-listed clinical-stage biopharmaceutical firm.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.